• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

Linalyl Acetate Inhibitor

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5758788

MBS5758788 is an inhibitor targeting Linalyl Acetate. Linalyl Acetate is a natural product More details

Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
Linalyl Acetate, Inhibitor
Full Product Name
Linalyl Acetate
Form/Format
Solid. Powder
Purity/Purification
99.52%
Preparation and Storage
Store at -20 degree C for 3 years powder
-80 degree C for 2 years in solvent
Molecular Weight
196.29
Solubility
<1mg/ml refers to the product slightly soluble or insoluble
Formula
C12H20O2
SMILES
CC(=O)OC(C)(CC\C=C(\C)C)C=C
CAS Number
115-95-7
Target & IC50
Others
In Vitro
Compared with nicotine alone, those treated with nicotine plus 10mg/kg (p = 0.036) and 100mg/kg (p = 0.023) linalyl acetate showed significant reductions in HR. Moreover, the addition of 1mg/kg (p = 0.011), 10mg/kg (p = 0.010), and 100mg/kg (p = 0.011) linalyl acetate to nicotine resulted in significantly lower LDH activity. Nicotine also showed a slight relaxation effect, followed by a sustained recontraction phase, whereas nicotine plus linalyl acetate or nifedipine showed a constant relaxation effect on contraction of mouse aorta (p <0.001). Furthermore, nicotine-induced increases in nitrite levels were decreased by treatment with linalyl acetate (p <0.001)[1].

Product References and Citations for Linalyl Acetate, inhibitor

Kim J R, Kang P, Hui Su Lee. Cardiovascular effects of linalyl acetate in acute nicotine exposure[J]. Environmental Health and Preventive Medicine, 2017, 22(1).
Kim J R, Kang P, Hui Su Lee. Cardiovascular effects of linalyl acetate in acute nicotine exposure[J]. Environmental Health and Preventive Medicine, 2017, 22(1).
Kwon S, Hsieh Y S, Shin Y K, et al. Linalyl acetate prevents olmesartan-induced intestinal hypermotility mediated by interference of the sympathetic inhibitory pathway in hypertensive rat[J]. Biomedicine & Pharmacotherapy, 2018, 102:362-368.
Kwon S, Hsieh Y S, Shin Y K, et al. Linalyl acetate prevents olmesartan-induced intestinal hypermotility mediated by interference of the sympathetic inhibitory pathway in hypertensive rat[J]. Biomedicine & Pharmacotherapy, 2018, 102:362-368.

Other Notes

Small volumes of Linalyl Acetate, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000